Matthew Curtis

Matthew Curtis is currently the Director of CVRM Regulatory Affairs at AstraZeneca, a role they commenced in 2024. They have extensive experience in regulatory affairs, having worked at companies such as Takeda Pharmaceuticals, where they served as North American Region Head, and Sarepta Therapeutics as Director of Regulatory Strategy. Previously, they held various positions in clinical research and regulatory roles at organizations including Sanofi Pasteur Biologics Co. and Fresenius Medical Care. Matthew's educational background includes a BS in Biology and Music from Northeastern University and a Master of Public Health from The George Washington University.